Date of Award


Document Type

Honors Thesis


Basic Biomedical Science

First Advisor

Dr. Victor Huber

Second Advisor

Dr. Michael Chaussee

Third Advisor

Dr. Grigoriy Sereda


Nanoparticles, macrophage, influenza, Streptococcus pyogenes, Fc receptor opsonization, flow cytometry

Subject Categories



Studies of past influenza pandemics have concluded that secondary bacterial infections are responsible for a high percentage of mortality. Apart from causing minor ailments, Streptococcus pyogenes, has been, and still is, a key bacterium studied in this field. Modern antibiotics have been able to reduce the threat posed by S. pyogenes, but with a vaccine currently in human trials the future in S. pyogenes defense is optimistic. Recent research has shown significant increases in survival of influenza virus:S. pyogenes super-infected mice when this bacterial vaccine is administered. Through development of an antibody-mediated nanoparticle uptake assay, we have been able to evaluate the contribution of vaccine-induced antibodies towards S. pyogenes clearance using murine macrophage cells. This newly developed assay has many possible applications for vaccine research. Our assay is novel in that it does not actually use the pathogen of study, but uses nanoparticles conjugated with proteins expressed on the outside of the pathogen. This eliminates any potential threat to using harmful microbes at the lab bench and is applicable to almost any microorganism. If developed into a cell-free system, this procedure could be used effectively in almost every clinic.

Included in

Biology Commons



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.